There is no question that many patients will have benefited from the pioneering work of the teams that brought forward clinically successful ADCs such as Mylotarg, Adcetris and Kadcyla. Yet as we know, there are a myriad of challenges involved, which is stifling further clinical progress of these promising molecules.
Over the past 9 years I have been attending World ADC San Diego to share, learn of significant innovations in the field, as well as discuss various approaches to dealing with these challenges.
World ADC provides the ideal forum to keep up to date with the fast pace of progress and innovation in this exciting area, and to connect with like-minded individuals who share tremendous enthusiasm for all that this therapeutic approach has to offer.
With a comprehensive agenda covering discovery, clinical development and manufacturing, this event has established itself as the must-attend meeting for the ADC community.
You’ll learn about new innovations in antibody-drug conjugates and to keep abreast of the tremendous progress in this burgeoning field of targeted therapeutics.
I enthusiastically invite you to join us for what will be another successful, enlightening meeting this fall.
Tim Lowinger – Mersana
Chairman of World ADC San Diego
"The conference is an awesome opportunity to learn what has been happening and also what to expect in the future, from both technology and business perspective"
“This conference is the preeminent ADC conference where the top companies come to present their data and share their experiences”
“Very informative, focused conference on all aspects of ADC research and development”